Latest data from September 24, 2021
Number of Health Center respondents = 13 (93% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 | 5,005 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) | 40.65% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 | 783 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) | 41.87% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, antigen)2 | Patients Tested Positive, Virus Detection (PCR, antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 55.08% | 53.90% |
| White, Hispanic/Latino Patients | 15.16% | 19.92% |
| Black/African American, Non-Hispanic/Latino Patients | 11.27% | 5.49% |
| Black/African American, Hispanic/Latino Patients | 0.14% | 0.13% |
| Asian Patients3 | 1.70% | 1.28% |
| American Indian/Alaska Native Patients3 | 1.36% | 0.89% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.56% | 0.89% |
| Patients with More than one race3 | 2.74% | 2.55% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 4.80% | 7.66% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 2.06% | 2.43% |
| Unreported/Refused to Report Race and Ethnicity | 5.13% | 4.85% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 604 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 70.19% |
| COVID-19 Immunization Series Completed | 815 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 66.37% |
| COVID-19 Immunization Series Additional | 41 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 24.39% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 28.48% | 32.27% | 75.61% |
| White, Hispanic/Latino Patients | 26.16% | 29.08% | 7.32% |
| Black/African American, Non-Hispanic/Latino Patients | 23.18% | 14.11% | 14.63% |
| Black/African American, Hispanic/Latino Patients | 0.33% | 0.25% | 0.00% |
| Asian Patients3 | 5.46% | 6.75% | 2.44% |
| American Indian/Alaska Native Patients3 | 0.83% | 3.80% | 0.00% |
| Native Hawaiian/Other Pacific Islander Patients3 | 4.30% | 4.79% | 0.00% |
| Patients with More than one race3 | 1.32% | 0.49% | 0.00% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 5.46% | 4.42% | 0.00% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 1.49% | 1.47% | 0.00% |
| Unreported/Refused to Report Race and Ethnicity | 2.98% | 2.58% | 0.00% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 23.08% |
| 1 to 24 Hours | 30.77% |
| More Than 24 Hours | 46.15% |
| N/A | 0.00% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 7.69% |
| Staffing to administer the vaccine | 0.00% |
| Vaccine confidence | 46.15% |
| Vaccine storage capacity | 0.00% |
| Vaccine supply | 7.69% |
| Other | 0.00% |
| None | 46.15% |
Operations and Staff
| Metrics | Value |
|---|---|
| Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits | 100.00% |
| Average Percent of Health Center Visits Conducted Virtually | 10.38% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 15.38% |
| Number of Mobile Van Sites | 2 |
| Number of Pop-up Clinics | 3 |
| Number of School-Based Vaccination Sites | 0 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 0.00% |
| Refer patients to another organization that provides monoclonal antibody therapies | 61.54% |
| None | 38.46% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 7.69% |
| Patient awareness/education | 7.69% |
| Staffing capacity | 15.38% |
| Therapy administration/onsite logistics | 15.38% |
| Other | 15.38% |
| None | 61.54% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
